These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 29883780

  • 1. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
    Zhao CL, Hui Y, Wang LJ, Yang D, Yakirevich E, Mangray S, Huang CK, Lu S.
    Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y.
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M, Toi PC, Siddaraju N, Ananthakrishnan R.
    Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
    [Abstract] [Full Text] [Related]

  • 7. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V.
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [Abstract] [Full Text] [Related]

  • 8. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
    Akiba J, Nakashima O, Hattori S, Naito Y, Kusano H, Kondo R, Nakayama M, Tanikawa K, Todoroki K, Umeno Y, Nakamura K, Sanada S, Yamaguchi R, Ogasawara S, Yano H.
    J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
    [Abstract] [Full Text] [Related]

  • 9. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T.
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [Abstract] [Full Text] [Related]

  • 10. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M, Kwok S, Yano H, Pai RK.
    Cancer Cytopathol; 2012 Aug 25; 120(4):230-7. PubMed ID: 22434791
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma: A clinicopathological and immunohistochemical study of 116 cases from a tertiary care hospital in Southern India.
    Hui M, Uppin SG, Uppin MS, Madhav TV, Varma GSR, Paul TR, Bheerappa N.
    Indian J Cancer; 2023 Aug 25; 60(2):191-198. PubMed ID: 37530240
    [Abstract] [Full Text] [Related]

  • 13. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V.
    Hum Pathol; 2017 Nov 25; 69():90-95. PubMed ID: 28970136
    [Abstract] [Full Text] [Related]

  • 14. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT, Shi J, Liu H, Lin F.
    Am J Clin Pathol; 2012 Aug 25; 138(2):203-10. PubMed ID: 22904131
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
    Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R.
    Cancer; 2002 Feb 25; 96(1):49-52. PubMed ID: 11836703
    [Abstract] [Full Text] [Related]

  • 16. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R, Nassar A, Cohen C, Siddiqui MT.
    Cancer Cytopathol; 2012 Aug 25; 120(4):223-9. PubMed ID: 22298472
    [Abstract] [Full Text] [Related]

  • 17. SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
    Mochizuki K, Kawai M, Odate T, Tahara I, Inoue T, Kasai K, Nakazawa T, Kondo T.
    Anticancer Res; 2018 Dec 25; 38(12):6865-6868. PubMed ID: 30504402
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.